Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of RIGImmune.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
RIGImmune
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
400 Farmington Avenue Farmington, CT 06032
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

With the strategic Subintro acquisition, RIGImmune will target intranasal delivery to amplify the mucosal innate immune and antiviral responses. RIGImmune is currently conducting IND-enabling activities for RIG-101 for the potential treatment of influenza.


Lead Product(s): RIG-101

Therapeutic Area: Infections and Infectious Diseases Product Name: RIG-101

Highest Development Status: IND EnablingProduct Type: Large molecule

Partner/Sponsor/Collaborator: RIGImmune

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition September 15, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY